Sam is the Global Head of Clinical Innovation at the Novartis Institutes for Biomedical Research, and leads a team focus on modernising and adapting clinical trials and pharmaceutical operations. This includes areas such as adding technology to trials to bring better and more meaningful data; how trials are run and where – in order to increase access and representation; as well as other aspects of patient centricity and trial decentralization.